Life Science

MetLife Adds Boston Life Science Asset for $103M

MetLife Investment Management has completed its $103 million purchase of Burlington BioCenter, a 109,085-square-foot life science research and pharmaceutical manufacturing facility in Burlington, Mass. Public records show MetLife financed the acquisition with a $54.4 million loan from Northwestern Mutual. Newmark represented the seller, a joint venture between The Gutierrez Company and GEM Realty Capital, and procured the buyer. The partnership had […]

Read more
Cape Air to buy 75 all-electric planes

Cape Air to buy 75 all-electric planes

ARLINGTON, Wash. (AP) — Eviation Aircraft, an Arlington company that has built a fully electric commuter airplane, got a boost this week when one of the nation’s largest commuter airlines, Cape Air, signed a letter of intent to buy 75 of the Eviation Alice model. The nine-passenger airplane, which produces no carbon emissions, is expected […]

Read more
Breakthrough Properties and CRISPR Therapeutics celebrate completion of The 105

Breakthrough Properties and CRISPR Therapeutics celebrate completion of The 105

Boston, MA Breakthrough Properties (Breakthrough), a leading global developer of life sciences real estate, celebrated the completion and grand opening of The 105 by Breakthrough (The 105) in collaboration with CRISPR Therapeutics. The new facility is fully leased to CRISPR Therapeutics and will serve as its new U.S. research & development headquarters. Located in one of […]

Read more
GI Partners Acquires 77K-SF Fully Leased Lab Building in Cambridge

GI Partners Acquires 77K-SF Fully Leased Lab Building in Cambridge

GI Partners has acquired Blackstone Science Square, a fully leased lab building in Cambridge, MA on behalf of its Essential Tech + Science Fund. According to GI Partners, Blackstone Science Square offered it the opportunity to acquire a stabilized, highly functional lab building situated in one of the country’s largest life sciences markets. The 77,000-square-foot property […]

Read more
President Biden wants to build a ‘bioeconomy.’ Here’s what that means for Boston.

President Biden wants to build a ‘bioeconomy.’ Here’s what that means for Boston.

President Joe Biden is infusing billions of dollars into a new, biotech-focused initiative, and it’s likely to have immediate ramifications for New England. Boston has long been a hotbed for pharmaceuticals in addition to upstart biotechs. But the White House is expanding the definition of what a “bioeconomy” could be, looking beyond drugmaking to other applications of […]

Read more

Compare